Overexpression of metabolic enzymes in T cells, such as phosphoenolpyruvate carboxykinase 1 (PCK1), has been shown to bolster T-cell functions and enhance the efficacy of adoptive T-cell therapy in mouse tumor models [63]. The gene discussed is PCK1; the disease is neoplasm.